Company intelligence / Profile preview

Lansdowne Labs

Ownership: Private
Development stage: Other

Overview

Landsdowne Labs develops advanced material science-based technologies to deactivate button batteries in the event of accidental ingestion, aiming to prevent injury and death, particularly in children. Their lead product, ChildLok™, is designed for global commercialization as a turnkey safety solution for consumer electronics manufacturers.

Therapeutic areas: Other
Modalities: Device
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Lansdowne Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lansdowne Labs.

Explore the full profile